Pages that link to "Q36283939"
Jump to navigation
Jump to search
The following pages link to Immune responses to human papillomavirus (Q36283939):
Displaying 50 items.
- Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus (Q26799574) (← links)
- Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia (Q27010447) (← links)
- A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers (Q27302754) (← links)
- HPV clearance and the neglected role of stochasticity (Q28652424) (← links)
- TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma (Q30491128) (← links)
- HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology (Q30794549) (← links)
- Determinants of seropositivity among HPV-16/18 DNA positive young women (Q30986936) (← links)
- Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment (Q33347618) (← links)
- Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer (Q33362569) (← links)
- A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females (Q33514126) (← links)
- The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma (Q33553561) (← links)
- Giant Condyloma Acuminatum of Vulva in an HIV-Infected Woman (Q33608047) (← links)
- The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus (Q33609914) (← links)
- Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa (Q33619797) (← links)
- High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men (Q33647410) (← links)
- DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women (Q33665786) (← links)
- hrHPV E5 oncoprotein: immune evasion and related immunotherapies. (Q33730462) (← links)
- Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). (Q33740390) (← links)
- Human papillomavirus vaccination: the population impact (Q33806566) (← links)
- Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes (Q33851664) (← links)
- Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer (Q33860352) (← links)
- Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda (Q33863369) (← links)
- Human papillomavirus 16 E5 modulates the expression of host microRNAs (Q33958050) (← links)
- Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination (Q34033823) (← links)
- Alternative dosage schedules with HPV virus-like particle vaccines (Q34102466) (← links)
- A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers (Q34121681) (← links)
- Factors affecting transmission of mucosal human papillomavirus (Q34149651) (← links)
- Association between toll-like receptor expression and human papillomavirus type 16 persistence (Q34187046) (← links)
- Human papillomavirus seropositivity and subsequent risk of HIV acquisition in rural South African women (Q34551969) (← links)
- HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress (Q34566683) (← links)
- Human papillomavirus testing in the prevention of cervical cancer (Q34616083) (← links)
- Immune therapy for human papillomaviruses-related cancers (Q34657561) (← links)
- Human papillomavirus disease and vaccines in adolescents (Q34675079) (← links)
- Viral carcinogenesis: factors inducing DNA damage and virus integration (Q34774880) (← links)
- Clinician's guide to human papillomavirus immunology: knowns and unknowns (Q34982885) (← links)
- Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). (Q35042272) (← links)
- Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer (Q35054754) (← links)
- A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study (Q35088658) (← links)
- Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus (Q35109451) (← links)
- Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival (Q35120785) (← links)
- HPV - immune response to infection and vaccination (Q35180148) (← links)
- Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort (Q35195833) (← links)
- Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females (Q35550810) (← links)
- Human papillomavirus vaccination: current indications and future directions (Q35558593) (← links)
- Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study) (Q35596329) (← links)
- Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development (Q35636308) (← links)
- High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa (Q35898044) (← links)
- Epithelial cell responses to infection with human papillomavirus (Q35940596) (← links)
- Giant Condyloma Acuminatum of Vulva Frustrating Treatment Challenge. (Q35957276) (← links)
- Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation. (Q35962518) (← links)